Registration included the opportunity for participants to submit advance questions to the presenters for dynamic interactive webinar.
Live Q&A will also be available at the end of webinar.
Free for ICHS members and most levels!
Free for Low/middle income, early career, global access attendees: includes a one-year membership
Non-members: $25USD - includes a one year membership
Join a panel of leading experts for an engaging session!
Description:
This webinar will provide dynamic, interactive content on the latest updates on Herpes Simplex Virus infections from the burden of the disease, the new definitions for resistant and refractory infections for clinical trials use, and how to manage complicated and severe HSV infections in immunocompromised patients, based on needs assessments and questions from the attendees.
The goal is to offer the following objectives and a comprehensive scientific session with insights into cutting-edge research, investigational clinical trials, innovative care practices, updated guidelines, and Q&A opportunities with a diverse range of experts.
Objectives:
Who should attend:
Physicians, Advanced Practice Providers, trainees including residents, fellows, and clinical pharmacists, caring for immunocompromised patients including patients with HIV.
Agenda:
HSV infection: The Hardship in an Immunocompromised Patient
Tali Shafat, MD
Update on the Burden of HSV Infections in Immunocompromised Patients: Gaps and Challenges
Genovefa (Zenia) Papanicolaou, MD, FIDSA, FASTCT
How To Diagnose Refractory and/or Resistant HSV Infection?
Anna Wald, MD, MPH
All speakers: Q&A
Speaker Bios:
Dr. Genovefa (Zenia) Papanicolaou
Audience-Driven Q&A – Expanding the discussion with questions submitted in advance and live inquiries during the session.
Please take advantage of these offerings which will provide you with the opportunity for future educational opportunities throughout the year.
If you need assistance with joining or renewing your membership, please contact us at admin@ichs.org